Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 9 of 9 for “"PLGA-PEG nanoparticles"”.

  1. Νανοδομημένα συστήματα μεταφοράς φαρμάκων με δυνατότητα διαπέρασης των βλεννωδών ιστών

    … functional mucus permeating nanoparticles were synthesized, using poly(lactic-co-glycolic acid) (PLGA) polymer modified with polyethylene glycol (PEG). A promising hypothesis prevails that coating particles with a high PEG density can efficiently reduce particle-mucus adhesive …

    greece Repository record for Νανοδομημένα συστήματα μεταφοράς φαρμάκων με δυνατότητα διαπέρασης των βλεννωδών ιστών (opens in a new tab)

  2. Rational Design of Protein-loaded Polymeric nanoparticles: A Computational and Experimental Approach

    … costs associated with medical care. Polymer nanoparticles (PNPs) can potentially address issues observed in enzymatic drug delivery due to their high surface area, ability to encapsulate a wide range of proteins, and ability to tailor the nanocarrier surface to minimize non-specific …

    washington Repository record for Rational Design of Protein-loaded Polymeric nanoparticles: A Computational and Experimental Approach (opens in a new tab)

  3. Development of tumour-targeted delivery systems entrapping plumbagin for cancer therapy

    … be formulated in transferrin-bearing liposomes, PLGA-PEG nanoparticles and lipid-polymer hybrid nanoparticles. The entrapment of plumbagin in these tumour-targeted nanomedicines led to an increase in plumbagin uptake by cancer cells, and improved its anti-proliferative and apoptosis activity in …

    strathclyde Repository record for Development of tumour-targeted delivery systems entrapping plumbagin for cancer therapy (opens in a new tab)

  4. PHARMACOKINETIC CHARACTERIZATION AND OPTIMIZATION OF POLY (LACTIDE-CO-GLYCOLIDE) NANOPARTICLES IN VIVO

    … to drugs and improve pharmacodynamics. Polymeric nanoparticles of Poly (lactide-co-glycolide) (PLGA) are proposed as suitable vehicles that desirably modify pharmacokinetics. The variability in PLGA and nanoparticle fabrication techniques results in nanoparticles with variable characteristics. It …

    sask Repository record for PHARMACOKINETIC CHARACTERIZATION AND OPTIMIZATION OF POLY (LACTIDE-CO-GLYCOLIDE) NANOPARTICLES IN VIVO (opens in a new tab)

  5. Corticosteroid-Encapsulated Nanoparticles in Thermoreversible Gels for the Amelioration of Choroidal Neovascularization in Age-Related Macular Degeneration

    … are being investigated exploring the use of nanoparticles and other polymeric materials. The goal of this project is to study the potential use of poly(lactide-co-glycolic acid)-polyethylene glycol (PLGA-PEG) nanoparticles in thermoreversible gels as localized sustained intraocular drug …

    vt Repository record for Corticosteroid-Encapsulated Nanoparticles in Thermoreversible Gels for the Amelioration of Choroidal Neovascularization in Age-Related Macular Degeneration (opens in a new tab)

  6. Engineering micro-vortex streaming via acoustofluidics

    … (ethylene glycol) (PLGA-PEG) nanoparticles by rapid mixing, high-molecular PLGA-PEG nanoparticles by strong mixing, PLGA-lipid core-shell nanoparticles by two-step mixing and chitosan nanoparticles by three-fluid mixing. When combined with varying flow rates and …

    duke Repository record for Engineering micro-vortex streaming via acoustofluidics (opens in a new tab)

  7. Targeting the LIN28B/let-7 axis by small molecules in Neuroblastoma

    … therefore we decided to include the molecule in PLGA-PEG nanoparticles to preserve its stability in solution and improve its activity. Upon encapsulation, we observed a substantial increase in molecule A effects, leading to a strong increment in mature let-7 miRNAs and a consequent inhibition of …

    trento Repository record for Targeting the LIN28B/let-7 axis by small molecules in Neuroblastoma (opens in a new tab)

  8. Hepatic AMPK Signaling and Pharmacological Activation During Liver Injury

    … MK-8722 (NP-MK8722) delivery. We determined that PLGA-PEG nanoparticles (NPs) accumulated in hepatic macrophages as early as 2 hours post-injection, but NP-MK8722 did not alter hepatic necrosis, injury, or immune infiltration. Overall, my thesis work has advanced our knowledge of the effects of …

    ottawa-retro Repository record for Hepatic AMPK Signaling and Pharmacological Activation During Liver Injury (opens in a new tab)